贝叶斯方法的预测性表现,用于预测危重病儿科患者治疗药物监测中的万科米辛度
Ha T Pham1,2, Cuc T Nguyen2, Tien T N Nguyen2
1Vietnam National Children's Hospital, Hanoi 11500, Vietnam.
Pharmaceutics
|February 27, 2026
概括
权重平衡贝叶斯方法准确地预测了使用仅一个血液样本在重症儿童中的万科米辛水平. 这种方法可以改善治疗药物监测 (TDM),以获得更好的患者结果.
科学领域:
- 药理动力学和药理动力学
- 儿科重症监护医学 儿科重症监护医学
- 计算生物学和生物信息学
背景情况:
- 对于重症儿科患者来说,准确的万科米辛度预测至关重要.
- 传统方法在预测该人群中药物水平方面可能存在局限性.
- 评估先进的贝叶斯算法和药理动力学模型是必要的.
研究的目的:
- 为了比较不同贝叶斯算法和第一阶药代动力学 (PK) 方法的有效性,用于万科米辛水平的预测.
- 确定影响这些预测方法准确性的因素.
- 优化儿科重症监护中的治疗药物监测 (TDM) 策略.
主要方法:
- 分析了110名重症儿科患者的队列,其中包括568个TDM样本.
- 三个贝叶斯算法 (传统,平面化,加权-平面化) 和Sawchuk-Zaske一阶PK方法被用于预测.
- 使用相对偏差 (rBias) 和相对根平均平方误差 (rRMSE) 评估预测性能,并使用线性混合效应模型识别影响因素.
主要成果:
- 所有方法都表现出可接受的性能,rBias <-20%和rRMSE约40%.
- 权重平衡贝叶斯算法在减少偏差和错误方面显著超过了传统的贝叶斯模型.
- 预测的准确性是可比的,不管使用一个或两个历史的康胺度.
结论:
- 使用单个血液样本的加权平面化贝叶斯方法是对危急儿童的万科米辛TDM的合适和有效方法.
- 这种方法提高了万科米辛度的可预测性,有助于临床决策.
- 这些发现支持采用这种先进的贝叶斯技术,以优化儿童重症监护机构的万科米辛治疗.
相关概念视频
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
301
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
301
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
336
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
336
01:20Estimation of k and VD of Aminoglycosides
286
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
286
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
250
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
250
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
381
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
381
01:29Therapeutic Drug Monitoring: Affecting Factors
288
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
288